Oral anticoagulation in patients aged 75 years or older with chronic non-valvar atrial fibrillation: effectiveness and safety in daily clinical practice

Observed cardioembolic risk factors were hypertension (197 of 279 (71%)), diabetes (64 (23%)), congestive heart failure (51 (18%)), a prior cardioembolic event (39 (14%)), atrial enlargement (31 (11%)), coronary heart disease (25 (9%)), and left ventricular dysfunction (18 (7%)). [...]treatment of p...

Full description

Saved in:
Bibliographic Details
Published in:Heart (British Cardiac Society) 2005-09, Vol.91 (9), p.1225-1226
Main Authors: Ruiz Ortiz, M, Romo Peñas, E, Franco Zapata, M F, Mesa Rubio, D, Anguita Sánchez, M, López Granados, A, Arizón del Prado, J M, Vallés Belsué, F
Format: Article
Language:English
Subjects:
Administration, Oral
Aged
Aged, 80 and over
Anticoagulants
Anticoagulants - therapeutic use
atrial fibrillation
Atrial Fibrillation - drug therapy
Biological and medical sciences
Cardiac dysrhythmias
Cardiology. Vascular system
Cardiovascular disease
Coagulation
Decision making
Disease-Free Survival
elderly
Female
Health risk assessment
Heart
Humans
Male
Medical sciences
prevention
Scientific Letters
stroke
Thromboembolism - prevention & control
Treatment Outcome
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Observed cardioembolic risk factors were hypertension (197 of 279 (71%)), diabetes (64 (23%)), congestive heart failure (51 (18%)), a prior cardioembolic event (39 (14%)), atrial enlargement (31 (11%)), coronary heart disease (25 (9%)), and left ventricular dysfunction (18 (7%)). [...]treatment of patients without contraindications and with only advanced age as a cardioembolic risk factor was left to the responsible physician to decide.
ISSN:1355-6037
1468-201X
DOI:10.1136/hrt.2004.050831